)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Valbiotis
Valbiotis (ALVAL) investor relations material
Valbiotis H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2025 earnings summary2 Mar, 2026
Executive summary
Achieved key milestones in commercial expansion in France and internationally, including major partnerships in Asia and the Middle East.
Expanded product portfolio and strengthened pharmacy distribution, doubling products available in pharmacies by year-end.
Reduced operating expenses by 30% while increasing commercial and marketing investments.
Built solid foundations for future growth, with a strong cash position supporting 2026 plans.
Financial highlights
2025 turnover reached €905,000, up from €175,000 in 2024, with Q4 sales of €400,000 (2.3x Q3 2025, 5x Q4 2024).
Net loss for 2025 was €9,417,000, an improvement from €10,025,000 in 2024.
Operating expenses decreased 30% to €10.54M, driven by an 80% reduction in R&D costs and 32% drop in overheads.
Cash and cash equivalents at year-end 2025 were €8.68M, providing visibility through end of 2026.
Positive cash impact of €4.2M from cost savings; capital increase in June 2025 raised €5.7M.
Outlook and guidance
Expects further acceleration in commercial momentum in 2026, with first international revenues from Asia and Middle East partnerships.
Ongoing discussions for new international partnerships.
Reaffirms 2027 goal: turnover >€25M and positive EBITDA in France; 2030 goal: turnover >€100M, EBITDA margin 25–30%.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Valbiotis
- Revenue surged to €4.73M, net loss halved, and €15M raised to fund 2024 commercial expansion.ALVAL
H2 202329 Jan 2026 - Launched first product, ended Nestlé deal, and posted €3.5M H1 loss with €18.5M cash.ALVALH1 202429 Jan 2026
- Transitioned to commercial operations, posted €10M net loss, and targets €25M+ revenue by 2027.ALVALH2 202429 Jan 2026
- Clinically validated natural supplements drive growth, targeting €100M+ revenue by 2030.ALVALInvestor presentation29 Jan 2026
- H1 2025 saw revenue growth and a €6.9M capital raise, but net loss increased to €4.6M.ALVALH1 202529 Jan 2026
Next Valbiotis earnings date
H1 202612 Oct, 2026
Valbiotis
Next Valbiotis earnings date
H1 202612 Oct, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage